Patents for A61K 49 - Preparations for testing in vivo (35,376)
08/2011
08/31/2011CN102167728A Improved gastrin releasing peptide compounds
08/31/2011CN102166503A Multifunctional polyelectrolyte microcapsule and template-free assembling method thereof
08/31/2011CN102166365A Preparation method of multiplex-mode iodized oil nano-emulsion contrast medium
08/31/2011CN102166344A Method for building rat uveitis model
08/31/2011CN102166232A Method for preparing animal model for cynomorium-causing syndrome of deficiency of kidney-yang
08/31/2011CN102166189A Target and fluorescence dual-functional slightly-soluble antitumor medicament nano structural lipid carrier
08/31/2011CN102166182A Nanometer probe and application thereof in tumor diagnosis composition and photodynamic therapy
08/31/2011CN101219225B Improved gastrin releasing peptide compounds
08/31/2011CN101200469B Separation of regioisomers of metal phthalocyanines
08/30/2011US8008502 Thiazoline acid derivatives
08/30/2011US8008435 Polymer stabilized neuropeptides
08/30/2011US8008088 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors
08/30/2011US8007770 Purified linear polypeptide epitopes from walnuts and associated methods
08/30/2011US8007769 Method for diagnosing an increased risk of preeclampsia by measuring the level of HIF-α
08/25/2011WO2011102789A1 Oligothiophene derivate as molecular probes
08/25/2011WO2011102626A2 Polyazamacrocyclic compound, and a production method and a biomedical use therefor
08/25/2011WO2011101602A1 Nanoemulsion for the delivery of at least two agents of interest
08/25/2011WO2011101445A1 High-affinity multivalent chelator compounds (mchs) and their use for the structural and functional analysis of target molecules
08/25/2011WO2011100829A1 Bifunctional chelating agents
08/25/2011WO2011059609A3 Dendrimer compositions and methods of synthesis
08/25/2011WO2011031042A3 Pegylated triiodinated aryl compound, and x-ray contrast agent comprising same
08/25/2011WO2010042476A3 Methods for making particles having long spin-lattice relaxation times
08/25/2011US20110208064 Curcumin Derivatives for Amyloid-Beta Plaque Imaging
08/25/2011US20110207963 Preparation of iodixanol
08/25/2011US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/25/2011US20110206619 Gold coated super paramagnetic iron oxide nano-particles (spions) and a method of synthesizing the same
08/25/2011US20110206618 Fluorescent labeling material and flourescent labeling agent
08/25/2011US20110206617 Modified polysaccharides for drug and contrast agent delivery
08/25/2011US20110206616 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
08/25/2011US20110206615 Probe reagent for measuring oxidative stress
08/25/2011US20110206614 Systemic instigation systems to study tumor growth or metastasis
08/25/2011US20110206613 METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
08/25/2011US20110206612 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
08/25/2011US20110206611 DNA Dendrimers as Thermal Ablation Devices
08/25/2011US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011US20110206609 Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes
08/25/2011US20110206607 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
08/25/2011US20110206604 Nitroimidazole-amino acid hypoxia contrast medium, preparation method and use thereof
08/25/2011US20110206603 Particulate materials and compositions for radio therapy
08/25/2011CA2789017A1 Oligothiophene derivate as molecular probes
08/24/2011EP2360258A2 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
08/24/2011EP2360172A2 Bipodal peptide binder
08/24/2011EP2359864A2 Targeting Vector-Phospholipid Conjugates
08/24/2011EP2359863A2 Isolation and use of solid tumor stem cells
08/24/2011EP2359809A1 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
08/24/2011EP2358399A1 Animal model for evaluating vasomotor response in vivo
08/24/2011EP1558616B2 Meso-substituted porphyrins
08/24/2011EP1506774B1 Smooth muscle peristole inhibitor
08/24/2011EP1126788B1 System for radiographic imaging of tissue
08/24/2011CN102164901A Process for the preparation of calcobutrol
08/24/2011CN102164591A Combinations of a rate control agent and an A-2-alpha receptor antagonist for use in multidetector computed tomography methods
08/24/2011CN102160894A Benzamide analog mediated brain-targeting delivery system
08/23/2011US8003136 Standardization of botanical products utilizing biological activity as a marker
08/23/2011US8003079 Core and core-shell nanoparticles containing iodine for X-ray imaging
08/23/2011CA2335488C Conformationally constrained backbone cyclized somatostatin analogs
08/18/2011WO2011100668A1 Methods and compositions of civamide to treat diseases of the intestines
08/18/2011WO2011097824A1 Preparation method of nano-gold particles used as contrast agent for x-ray or computerized tomography (ct)
08/18/2011WO2011079317A3 Ultrasound-activated nanoparticles as imaging agents and drug delivery vehicles
08/18/2011WO2011049961A3 Compositions and methods for imaging cells
08/18/2011WO2011047277A3 Release of agents from cells
08/18/2011US20110203007 Assays of neurodegenerative disorders, including frontotemporal dementia and amyotrophic lateral sclerosis
08/18/2011US20110201940 Renal Function Analysis Method and Apparatus
08/18/2011US20110201910 Integrated receiver for continuous analyte sensor
08/18/2011US20110201044 Tuberculosis diagnostic test
08/18/2011US20110200695 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue
08/18/2011US20110200536 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
08/18/2011US20110200535 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
08/18/2011US20110200534 T1-T2 Dual Modal MRI Contrast Agents
08/18/2011US20110200533 Compounds for the diagnosis of diseases associated with vcam expression
08/18/2011US20110200532 Fluorescent emulsion of indocyanine green
08/18/2011US20110200531 Treatment and diagnosis of central nervous system disorders
08/18/2011US20110200530 Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same
08/18/2011US20110200529 Activatable bioluminescent probe system and method of use thereof
08/18/2011US20110200528 Cyclized ngr peptide compounds, compositions, and methods of their use
08/18/2011US20110200527 Peptide Ligand Directed Drug Delivery
08/18/2011US20110200525 Vhh antibody fragments for use in the detection and treatment of cancer
08/18/2011DE19926728B4 Verwendung von Trägermaterialien und diagnostisch nutzbaren Zusatzstoffen in Abbildungsverfahren für intraorale Diagnosezwecke Use of support materials and diagnostically useful additives in imaging method for intraoral diagnostic purposes
08/18/2011DE102010008417A1 Hochaffine multivalente Chelatorverbindungen (MCHs) und deren Verwendung zur Struktur- und Funktionsanalyse von Zielmolekülen High-affinity multivalent chelator compounds (MCH) and their use in structural and functional analysis of target molecules
08/18/2011DE102004045186B4 Liposomen, die die intrazelluläre Penetration von Wirkstofen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of Wirkstofen, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration
08/17/2011EP2357187A1 Molecules with extended half-lives, compositions and uses thereof
08/17/2011EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
08/17/2011EP2355847A1 Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1)
08/17/2011EP1795604B1 Telomelysin-gfp gene-containing recombinant virus
08/17/2011EP1644330B1 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
08/17/2011EP1617819B1 Radioactively marked microparticles, method for the production thereof and use of the same
08/17/2011CN1795198B Glycerophosphocholine and its derivatives for medical imaging of neuropsychiatric disorders
08/17/2011CN102159253A Image-guided therapy of myocardial disease: composition, manufacturing and applications
08/17/2011CN102159252A Molecular probe precursor for imaging of pancreatic islet, and use thereof
08/17/2011CN102154209A Human osteosarcoma cell strain and application thereof
08/17/2011CN102153871A Preparation method for chiral dendrimers/gold nanoparticles modified by mPEG
08/17/2011CN102151336A Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor
08/16/2011US7998934 PAI-2 conjugates for the treatment and imaging of cancer
08/16/2011US7998704 Methods for magnetic resonance imaging
08/16/2011US7998477 Spherical protein particles and methods for making and using them
08/16/2011US7998461 Salmonella cancer therapeutics and related therapeutic methods
08/16/2011US7998460 Prevention of deficits in neurogenesis with anti-inflammatory agents
08/16/2011CA2493041C Injectable pharmaceutical composition for treating post-operative joint pain comprising an amide local anesthetic
08/16/2011CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same
08/11/2011WO2011097633A2 Egf receptor mimicking peptides
08/11/2011WO2011095311A1 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 354